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Abstract
We attempt to set a mathematical foundation of immunology and
amino acid chains. To measure the similarities of these chains, a kernel
on strings is defined using only the sequence of the chains and a good
amino acid substitution matrix (e.g. BLOSUM62). The kernel is used
in learning machines to predict binding affinities of peptides to hu-
man leukocyte antigen DR (HLA-DR) molecules. On both fixed allele
[24] and pan-allele [23] benchmark databases, our algorithm achieves
the state-of-the-art performance. The kernel is also used to define a
distance on an HLA-DR allele set based on which a clustering anal-
ysis precisely recovers the serotype classifications assigned by WHO
[14, 22]. These results suggest that our kernel relates well the chain
structure of both peptides and HLA-DR molecules to their biological
functions, and that it offers a simple, powerful and promising method-
ology to immunology and amino acid chain studies.
1 Introduction
Large scientific and industrial enterprises are engaged in efforts to produce
new vaccines from synthetic peptides. The study of peptide binding to ap-
propriate alleles is a major part of this effort. Our goal here is to support
the use of a certain “string kernel” for peptide binding prediction as well as
for the classification of supertypes of the major histocompatibility complex
(MHC) alleles.
Our point of view is that some key biological information is contained in
just two places: first, in a similarity kernel (or substitution matrix) on the
∗The work described in this paper is supported by GRF grant [Project No.
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set of the fundamental amino acids; and second, on a good representation of
the relevant alleles as strings of these amino acids. Our results bear this out.
This is achieved with great simplicity and predictive power. Along the
way we find that gaps and their penalties in the string kernels don’t help,
and that emphasizing peptide binding as a real-valued function rather than
a binding/non-binding dichotomy clarifies the issues. We use a modification
of BLOSUM62 followed by a Hadamard power. We also use regularized
least squares (RLS) in contrast to support vector machines as the former is
consistent with our regression emphasis.
We next briefly describe the construction (more details also in Section
2) of our main kernel Kˆ3 on amino acid chains, inspired by local alignment
kernels (see e.g. [30]) as well as an analogous kernel in vision (see [38]) begins.
For the purposes of this paper, a kernelK is a symmetric functionK : X×
X → R where X is a finite set. Given an order on X , K may be represented
as a matrix (think of X as the set of indices of the matrix elements). Then
it is assumed that K is positive definite (in such a representation).
Let A be the set of the 20 basic (for life) amino acids. Every protein has
a representation as a string of elements of A .
Step 1. Definition of a kernel K1 : A ×A → R.
BLOSUM62 is a similarity (or substitution) matrix on A frequently
used in immunology [13]. In the formulation of BLOSUM62, a kernel
Q : A × A → R is defined using blocks of aligned strings of amino
acids representing proteins. One can thinkQ as the “raw data” of BLO-
SUM62. It is symmetric, positive-valued, and a probability measure on
A ×A . (We have in addition checked that it is positive definite.)
Let p be the marginal probability defined on A by Q. That is,
p(x) =
∑
y∈A
Q(x, y).
Next, we define the BLOSUM62-2 matrix, indexed by the set A , as
[BLOSUM62-2](x, y) =
Q(x, y)
p(x)p(y)
.
We list the BLOSUM62-2 matrix in Appendix A. Suppose β > 0 is
a parameter, usually chosen about 1
8
or 1
10
(still mysterious). Then a
kernel K1 : A ×A → R is given by
K1(x, y) = ([BLOSUM62-2](x, y))β . (1)
Note that the power in (1) is of the matrix entries, not of the matrix.
Step 2. Let A 1 = A and define A k+1 = A k × A recursively for any
k ∈ N. We say s is an amino acid chain (or string) if s ∈ ∪∞k=1A
k,
and s = (s1, . . . , sk) is a k-mer if s ∈ A
k for some k ∈ N with si ∈ A .
Consider
K2k(u, v) =
k∏
i=1
K1(ui, vi)
where u, v are amino acid strings of the same length k, u = (u1, . . . , uk),
v = (v1, . . . , vk); u, v are k-mers. K
2
k is a kernel on the set of all k-mers.
2
Step 3. Let f = (f1, · · · , fm) be an amino acid chain. Denote by |f | the
length of f (so here |f | = m). Write u ⊂ f whenever u is of the form
u = (fi+1, · · · , fi+k) for some 1 ≤ i+ 1 ≤ i+ k ≤ m. Let g be another
amino acid chain, then define
K3(f, g) =
∑
u⊂f,v⊂g
|u|=|v|=k
all k=1,2,...
K2k(u, v),
for f and g in any finite set X of amino acid chains. Here, and in all of
this paper, we abuse the notation to let the sum count each occurrence
of u in f (and of v in g). In other words we count these occurrences
“with multiplicity”. While u and v need to have the same length, not
so for f and g. Replacing the sum by an average gives a different but
related kernel.
We define the correlation kernel Kˆ normalized from any kernel K by
Kˆ(x, y) =
K(x, y)√
K(x, x)K(y, y)
.
In particular, let Kˆ3 be the correlation kernel of K3.
Remark 1. Kˆ3 is a kernel (see Section 2.2). It is symmetric, positive defi-
nite, positive-valued; it is basic for the results and development of this paper.
We sometimes say string kernel. The construction works for any kernel (at
the place of K1) on any finite alphabet (replacing A ).
Remark 2. For some background see [12, 29, 31, 17]. But we use no gap
penalty or even gaps, no logarithms, no implied round-offs, and no alignments
(except the BLOSUM62-2 matrix which indirectly contains some alignment
information). Our numerical experiments indicate that these don’t help in
our context, (at least!).
Remark 3. For complexity reasons one may limit the values of k in Step 3
with a small loss of accuracy, or even choose the k-mers at random.
Remark 4. The chains we use are proteins, peptides, and alleles. Peptides
are short chain fragments of proteins. Alleles are realizations of genes in
living organisms varying with the individual; as proteins they have represen-
tations as amino acid chains.
MHC II and MHC I are sets of alleles which are associated with immuno-
logical responses to viruses, bacteria, peptides and related. See [20, 10] for
good introductions. In this paper we only study HLA II, the MHC II in
human beings. HLA-DRB (or simply DRB) describes a subset of HLA II
alleles which play a central role in immunology, as well as in this paper.
1.1 First Application: Binding Affinity Prediction
Peptide binding to a fixed HLA II (and HLA I as well) molecule (or an allele)
a is a crucial step in the immune response of the human body to a pathogen
or a peptide-based vaccine. Its prediction is computed from data of the form
3
(xi, yi)
m
i=1, xi ∈ Pa and yi ∈ [0, 1], where Pa is a set of peptides (i.e. chains
of amino acids; in this paper we study peptides of length 9 to 37 amino
acids, usually about 15) associated to an HLA II allele a. Here yi expresses
the strength of the binding of xi to a. The peptide binding problem occupies
much research. We may use our kernel Kˆ3 described above for this problem
since peptides are represented as strings of amino acids. Our prediction thus
uses only the amino acid chains of the peptides, a substitution matrix, and
some existing binding affinities (as “data”).
Following RLS supervised learning with kernel K = Kˆ3, the main con-
struction is to compute
fa = arg min
f∈HK
m∑
i=1
(f(xi)− yi)
2 + λ‖f‖2K. (2)
Here λ > 0 and the index β > 0 in Kˆ3 are chosen by a procedure called
leave-one-out cross validation. Also HK is the space of functions spanned
by {Kx : x ∈ P} (where Kx(y) := K(x, y)) on a finite set P of peptides
containing Pa. An inner product on HK is defined on the basis vectors
as 〈Kx, Ky〉HK = K(x, y), then in general by linear extension. The norm
of f ∈ HK induced by this inner product is denoted by ‖f‖K . In (2), fa
is the predicted peptide binding function. We refer to this algorithm as
“KernelRLS”.
For the set of HLA II alleles, with the best data available we have Table
1. The area under the receiver operating characteristic curve (area under
the ROC curve, AUC) is the main measure of accuracy used in the pep-
tide binding literature. NN-W refers to the algorithm which up to now has
achieved the most accurate results for this problem, although there are many
previous contributions as [41, 18, 8]. In Section 2 there is more detail.
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List of alleles, a #Pa
KernelRLS NN-W in [24]
RMSE AUC AUC
DRB1*0101 5166 0.18660 0.85707 0.836
DRB1*0301 1020 0.18497 0.82813 0.816
DRB1*0401 1024 0.24055 0.78431 0.771
DRB1*0404 663 0.20702 0.81425 0.818
DRB1*0405 630 0.20069 0.79296 0.781
DRB1*0701 853 0.21944 0.83440 0.841
DRB1*0802 420 0.19666 0.83538 0.832
DRB1*0901 530 0.25398 0.66591 0.616
DRB1*1101 950 0.20776 0.83703 0.823
DRB1*1302 498 0.22569 0.80410 0.831
DRB1*1501 934 0.23268 0.76436 0.758
DRB3*0101 549 0.15945 0.80228 0.844
DRB4*0101 446 0.20809 0.81057 0.811
DRB5*0101 924 0.23038 0.80568 0.797
Average 0.21100 0.80260 0.798
Weighted Average 0.20451 0.82059 0.810
Table 1: The algorithm performance of RLS on each fixed allele in the bench-
mark [24]. If a is the allele in column 1, then the number of peptides in Pa
is given in column 2. The root-mean-square deviation (RMSE) scores are
listed (see Section 2). The AUC scores of the RLS and the NN-W algorithm
are listed for comparison, where a common threshold θ = 0.4256 is used [24]
in the final thresholding step into binding and non-binding (see Section 2.3
for the details). The best AUC in each row is marked in bold. In all the
tables the weighted average scores are given by the weighting on the size
#Pa of the corresponding peptide sets Pa.
We note the simplicity and universality of the algorithm that is based
on Kˆ3, which itself has this simplicity with the contributions from the sub-
stitution matrix (i.e. BLOSUM62-2) and the sequential representation of
the peptides. There is an important generalization of the peptide binding
problem where the allele is allowed to vary. Our results on this problem are
detailed in Section 3.
1.2 Second Application: Clustering and Supertypes
We consider the classification problem of DRB (HLA-DR β chain) alleles
into groups called supertypes as follows. The understanding of DRB sim-
ilarities is very important for the designation of high population coverage
vaccines. An HLA gene can generate a large number of allelic variants and
this polymorphism guarantees a population from being eradicated by an sin-
gle pathogen. Furthermore, there are no more than twelve HLA II alleles in
each individual [16] and each HLA II allele binds only to specific peptides
[33, 43]. As a result, its difficult to design an effective vaccine for a large
population. It has been demonstrated that many HLA molecules have over-
lapping peptide binding sets and there have been several attempts to group
them into supertypes accordingly [36, 34, 37, 26, 19, 2, 4]. The supertypes
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are designed so that the HLA molecules in the same supertype will have a
similar peptide binding specificity.
The Nomenclature Committee of the World Health Organization (WHO)
[22] has given extensive tables on serological type assignments to DRB alle-
les which are based on the works of many organizations and labs throughout
the world. In particular the HLA dictionary 2008 by Holdsworth et al. [14]
acknowledges especially the data from the WHO Nomenclature Committee
for Factors of the HLA system, the International Cell Exchange and the
National Marrow Donor Program. The text in Holdsworth et al., 2008 [14]
indicates also the ambiguities of such assignments especially in certain sero-
logical types.
We define a set N of DRB alleles as follows. We downloaded 820 DRB
allele sequences from the IMGT/HLA Sequence Database [27] 1. And then
14 non-expressed alleles were excluded and there remained 806 alleles. We
use two markers “RFL” and “TVQ”, each of which consists of three amino
acids to identify the polymorphic part of a DRB allele. For each allele,
we only consider the amino acids located between the markers “RFL” (the
location of the first occurrence of “RFL”) and “TVQ” (the location of the last
occurrence of “TVQ”). One reason is the majority of polymorphic positions
occur in exon 2 of the HLA class II genes [11], and the amino acids located
between the markers “RFL” and “TVQ” constitute the whole exon 2 [40].
The DRB alleles are encoded by 6 exons. Exon 2 is the most important
component constituting an HLA II-peptide binding site. The other reason is
in the HLA pseudo-sequences used in the NetMHCIIpan[25], all positions of
the allele contacting with the peptide occur in this range.
Thus each allele is transformed into a normal form. We should note that
two different alleles may have the same normal form. For those alleles with
the same normal form, we only consider the first one. The order is according
to the official names given by WHO. We collect the remaining 786 alleles
with no duplicate normal forms into a set, we call N . This set not only
includes all alleles listed in the tables of [14], but also contains all new alleles
since 2008 until August 2011.
Thus N may be identified with a set of amino acid sequences. Next
impose the kernel Kˆ3 above on N where β = 0.06, we call the kernel Kˆ3
N
.
On N we define a distance derived from Kˆ3
N
by
DL2(x, y) =
(
1
#N
∑
z∈N
(
Kˆ3N (x, z)− Kˆ
3
N (y, z)
)2)1/2
, ∀x, y ∈ N . (3)
Here and in the sequel we denote #A the size of a finite set A.
The DRB1*11 and DRB1*13 families of alleles have been the most dif-
ficult to deal with by WHO and for us as well. Therefore we will exclude
the DRB1*11 and DRB1*13 families of alleles in the following cluster tree
construction with the evidence that clustering of these 2 groups is ineffective.
They are left to be analyzed separately.2
The set M consists of all DRB alleles except for the DRB1*11 and
DRB1*13 families of alleles. M is a subset of the set N . We produce a
1ftp://ftp.ebi.ac.uk/pub/databases/imgt/mhc/hla/DRB prot.fasta
2We have found from a number of different experiments that “they do not cluster”.
Perhaps the geometric phenomenon here is in the higher dimensional scaled topology, i.e.
the betti numbers bi > 0, for i > 0.
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clustering of M based on the L2 distance DL2 restricted to M , and use
the OWA (Ordered Weighted Averaging) [42] based linkage instead of the
“single” linkage in the hierarchical clustering algorithm.
This clustering uses no previous serological type information and no align-
ments. We have assigned supertypes labeled ST1, ST2, ST3, ST4, ST5, ST6,
ST7, ST8, ST9, ST10, ST51, ST52 and ST53 to certain clusters in the Tree
shown in Figure 1 based on contents of the clusters described in Table 6. Pep-
tides have played no role in our model. Differing from the artificial neural
network method [21, 14], no “training data” of any previously classified alle-
les are used in our clustering. We make use of the DRB amino acid sequences
to build the cluster tree. Only making use of these amino acid sequences,
our supertypes are in exact agreement with WHO assigned serological types
[14], as can be seen by checking the supertypes against the clusters in Table
6.
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Figure 1: Cluster tree on 559 DRB alleles. The diameters of the leaf nodes
are given at the bottom of the figure. The numbers given in the figure are
the diameters of the corresponding unions of clusters.
This second application is given in some detail in Section 4.
2 Kernel Method for Binding Affinity Pre-
diction
In this section we describe in detail the construction of our string kernel.
The motivation is to relate the sequence information of strings (peptides
or alleles) to their biological functions (binding affinities). A kernel works
as a measure of similarity and supports the application of powerful machine
learning algorithms such as RLS which we use in this paper. For a fixed allele,
binding affinity is a function on peptides with values in [0, 1]. The function
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values on some peptides are available as the data, according to which RLS
outputs a function that predicts for a new peptide the binding affinity to the
allele. The method is generalized in the next section to the pan-allele kernel
algorithm that takes also the allele structure into account.
2.1 Kernels
We suppose throughout the paper that X is a finite set. We now give the
definition of a kernel, of which an important example is our string kernel.
Definition 1. A symmetric function K : X ×X → R is called a kernel on
X if it is positive definite, in the sense that by choosing an order on X, K
can be represented as a positive definite matrix (K(x, y))x,y∈X.
Kernels have the following properties [5, 35, 1].
Lemma 1. (i) If K is a kernel on X then it is also a kernel on any subset
X1 of X.
(ii) If K1 and K2 are kernels on X, then K : X ×X → R defined by
K(x, x′) = K1(x, x
′) +K2(x, x
′)
is also a kernel.
(iii) If K1 is a kernel on X1 and K2 is a kernel on X2, then K : (X1 ×
X2)× (X1 ×X2)→ R defined by
K((x1, x2), (x
′
1, x
′
2)) = K1(x1, x
′
1) ·K2(x2, x
′
2)
is a kernel on X1 ×X2.
(iv) If K is a kernel on X, and f is a real-valued function on X that
maps no point to zero, then K ′ : X ×X defined by
K ′(x, x′) = f(x)K(x, x′)f(x′)
is also a kernel.
(v) If K(x, x) > 0 for all x ∈ X, then the correlation normalization Kˆ of
K given by
Kˆ(x, x′) =
K(x, x′)√
K(x, x)K(x′, x′)
(4)
is also a kernel.
Proof. (i), (ii) and (iv) follows the definition directly. (iii) follows the fact
that the Kronecker product of two positive definite matrices is positive defi-
nite; see [15] for details. The positive definiteness of a kernel K guarantees
that K(x, x) > 0 for any x in X , so (v) follows (iv).
Remark 5. Notice that with correlation normalization we have Kˆ(x, x) = 1
for all x ∈ X. This is a desired property because the kernel function is usually
used as a similarity measure, and with Kˆ we can say that each x ∈ X is
similar to itself.
Define the real-valued function on X , Kx, by Kx(y) = K(x, y). The func-
tion space HK = span{Kx : x ∈ X} is a Euclidean space with inner product
〈Kx, Ky〉 = K(x, y), extended linearly to HK . The norm of a function f in
HK is denoted as ‖f‖K .
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Remark 6. The kernel can be defined even without assuming X is finite; in
this general case the kernel is referred to as a reproducing kernel [1]. If X is
finite then a reproducing kernel is equivalent to our “kernel”. The theory of
reproducing kernel Hilbert spaces plays an important role in learning [5, 32].
On a finite set X there are two notions of distance derived from a kernel
K. The first one is the usual distance in HK , that is
DK(x, x
′) = ‖Kx −Kx′‖K ,
for two points x, x′ ∈ X . The second one is the L2 distance defined by
DL2(x, x
′) =
(
1
#X
∑
t∈X
(K(x, t)−K(x′, t))
2
) 1
2
.
Important examples of the kernels discussed above are our kernel K3 and
its normalization Kˆ3, both defined on any finite X ⊂ ∪k≥1A
k
2.2 Kernel on Strings
We start with a finite set A called the alphabet. In the work here A is
the set of 20 amino acids, but the theory in this section applies to any other
finite set. For example, as the name suggests, it can work on text for semantic
analysis with a similar setting. See also [38] for the framework in vision.
To measure a similarity among the 20 amino acids, Henikoff and Henikoff
[13] collect families of related proteins, align them and find conserved regions
(i.e. regions that do not mutate frequently or greatly) as blocks in the fami-
lies. The occurrence of each pair of amino acids in each column of every block
is counted. A large number of occurrences indicate that in the conserved re-
gions the corresponding pair of amino acids substitute each other frequently,
or in another way of saying, that they are similar. A symmetric matrix Q
indexed by A ×A is eventually obtained by normalizing the occurrences, so
that
∑
x,y∈A Q(x, y) = 1 and Q(x, y) indicates the frequency of occurrences.
See [13] for details. The BLOSUM62 matrix is constructed accordingly.
Define K1 : A ×A → R as
K1(x, y) =
(
Q(x, y)
p(x)p(y)
)β
, for some β > 0,
where p : A → [0, 1] given by
p(x) =
∑
y∈A
Q(x, y),
is the marginal probability distribution on A . When β = 1, we name the
matrix (K1(x, y))x,y∈A as BLOSUM62-2 (one takes logarithm with base 2,
scales it with factor 2, and rounds the obtained matrix to integers to obtain
the BLOSUM62 matrix). Notice that if one chooses simply Q = 1
m
Im×m,
then one obtains the matrix Im×m as the analogue of the BLOSUM62-2, and
the corresponding K3 of the introduction is called the spectrum kernel [17].
In matrix language K1 is the Hadamard power of the BLOSUM62-2 ma-
trix, where for a matrix M = (Mi,j) with positive entries and a number
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β > 0, we denote M◦β as the β’th Hadamard power of M and log◦M as the
Hadamard logarithm of M , and their (i, j) entries are respectively,
(M◦β)i,j := (Mi,j)
β, (log◦M)i,j := log(Mi,j).
Theorem 1 (Horn and Johnson[15]). Let A be an m × m positive-valued
symmetric matrix. The Hadamard power A◦β is positive definite for any
β > 0 if and only if the Hadamard logarithm log◦A is conditionally positive
definite (i.e. positive definite on the space V = {v = (v1, · · · , vm) ∈ R
m :∑m
i=1 vi = 0}).
Proposition 1. Every positive Hadamard power of BLOSUM62-2 is positive
definite. Thus the above defined K1 is a kernel for every β > 0.
Proof. One just shows the eigenvalues of the Hadamard logarithm on V are
all positive. One checks this by computer.
Theorem 2. Based on any kernel K1, the functions K2k , K
3, and Kˆ3 defined
as in the introduction are all kernels.
Proof. The fact that K2k is a kernel for k ≥ 1 follows from Lemma 1 (iii). We
now prove that K3 is positive definite on any finite set X of strings, which
then implies the same for Kˆ3 by Lemma 1 (v). From Lemma 1 (i) it suffices
to verify the cases that X = Xk = ∪
k
i=1A
i for k ≥ 1. When k = 1, K3 is just
K1 and hence positive definite. We assume now that K3 is positive definite
on Xk with k = n.
We claim that the matrices indexed by Xn+1,
K3i,Xn+1(f, g) =
{ ∑
u⊂f,v⊂g
|u|=|v|=i
K2(u, v) if |f |, |g| ≥ i,
0 if |f | < i or |g| < i,
are all positive semi-definite. In fact, for any 1 ≤ i ≤ n,
K3i,Xn+1 = PiK
2
i P
T
i , (5)
where K2i is the matrix (K
2
i (u, v))u,v∈A i , and Pi is a matrix with Xn+1 as the
row index set and A i as the column index set, and for any f ∈ Xn+1 and
u ∈ A i, Pi(f, u) counts the number of times u occurs in f . Let us explain
equation (5) a little more. For f and g in Xn+1, from the definition of Pi we
have
(PiK
2
i P
T
i )(f, g) =
∑
u,v∈A i
Pi(f, u)Pi(g, v)K
2
i (u, v) =
∑
u⊂f,v⊂g
|u|=|v|=i
K2i (u, v), ∀i. (6)
Summing the equation (6) above over i ∈ N gives the definition of K3(f, g).
For i = n+ 1, we have
K3n+1,Xn+1(f, g) =
{
0 f 6∈ A n+1 or g 6∈ A n+1,
K2n+1(f, g) otherwise.
Therefore K3n+1,Xn+1 is positive definite on A
n+1, and is zero elsewhere. Since
K3(f, g) =
n∑
i=1
K3i,Xn+1(f, g), ∀f, g ∈ Xn,
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we know that the sum of K3i,Xn+1 with i = 1, · · · , n are positive definite on
Xn, and positive semi-definite on Xn+1. Because
K3(f, g) =
n+1∑
i=1
K3i,Xn+1(f, g), ∀f, g ∈ Xn+1,
we see that K3 is positive definite on Xn+1.
Corollary 1. Our kernels K2k , K
3 and Kˆ3 are discriminative. That is,
given any two strings f, g in the domain of K, as long as f 6= g, we have
DK(f, g) > 0. Here K stands for any of the three kernels.
2.3 First Application: Peptide Affinities Prediction
We first briefly review the RLS algorithm inspired by learning theory. Let K
be a kernel on a finite set X . Write HK to denote the inner product space
of functions on X defined by K. Suppose z¯ = {(xi, yi)}
m
i=1 is a sample set
(called the training set) with xi ∈ X and yi ∈ R for each i. The RLS uses a
positive parameter λ > 0 and z¯ to generate the output function fz¯,λ : X → R,
defined as
fz¯,λ = arg min
f∈HK

 1#z¯
∑
(xi,yi)∈z¯
(f(xi)− yi)
2 + λ‖f‖2K

 . (7)
Since HK is of finite dimension, one solves (7) by representing f linearly by
functions Kx with x ∈ X and finding the coefficients. See [5, 32] for details.
Remark 7. The RLS algorithm (7) is independent of the choice of the un-
derlying space X where the function space HK is defined, in the sense that
the predicted values fz¯,λ(x) at x ∈ X will not be changed if we extend K onto
a large set X ′ ⊃ X and re-run (7) with the same z¯ and λ. This is guaranteed
by the construction of the solution. See, e.g. [5, 32].
Five-fold cross validation is employed to evaluate the performance of the
algorithms. Suppose z¯ is partitioned into five divisions (we assume m ≥ 5,
which is always the case in this paper). Five-fold cross validation is the
procedure that validates an algorithm (with fixed parameters) as follows. We
choose one of the five divisions of the data for testing, train the algorithm on
the remaining four divisions, and predict the output function on the testing
division. We do this test for five times so that each division is used in one
time as the testing data and thus every sample xi is labeled with both the
observed value yi and the predicted value y˜i. The algorithm performance is
obtained by comparing the two values over all the sample set. Similarly one
defines the n-fold cross validation for any n ≤ m. As an important special
instance, the m-fold case is also referred to as leave-one-out cross validation.
Cross validations are also used to tune parameters.
Binding affinity measures the strength that a peptide binds to an allele,
and is represented by the IC50 score. Usually an IC50 score lies between 0
and 50,000 (nano molar). A widely used IC50 threshold determining binding
and non-binding is 500 (“binding” if the IC50 value is less than 500). The
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bioinformatics community usually normalizes the scores by the function ψb :
(0,+∞)→ [0, 1] with a base b > 1,
ψb(x) :=


0 x > b,
1− logb x 1 ≤ x ≤ b,
1 x < 1.
(8)
Without introducing any ambiguity we will in the sequel refer to the normal-
ized IC50 value as the binding affinity using an appropriate value of b.
We test the kernel with RLS on the IEDB benchmark data set published
on [25]. The data set covers 14 DRB alleles, each allele a with a set Pa
of peptides. For any p ∈ Pa, its sequence representation and the [0, 1]-
valued binding affinity ya,p to the allele a are both given. On this data
set we compare our algorithm with the state-of-the-art NN-align algorithm
proposed in [24]. In [24] for each allele a, the peptide set Pa was divided
into 5 parts for validating the performance3.
Now fix an allele a. Set X = P ⊃ Pa (Remark 7 shows that one
may select any finite P that contains Pa here). Define the kernel Kˆ
3 on
X through the steps in the Introduction (leaving the power index β to be
fixed). We use the same 5-fold partition Pa = ∪
5
t=1Pa,t as in [25], and
use five-fold cross validation to test our algorithm (7) with K = Kˆ3. In
the t’th test (t = 1, · · · , 5) four parts of Pa are merged to be the training
data, denoted as P
(t)
a = Pa\Pa,t, and Pa,t is left as the testing data. For
fixed t and a, we further tune the parameter β in Kˆ3 and the regularization
parameter λ in (7) by leave-one-out cross validation with z¯ = P
(t)
a . Every
pair of β in the geometric sequence {0.001, · · · , 10} of length 30 and λ in the
geometric sequence {e−17, · · · , e−3} of length 15 is tested. With the optimal
pair (β
(t)
a , λ
(t)
a ), we train the RLS (7) once more on P
(t)
a to give the predicted
binding function f
P
(t)
a ,λ
(t)
a ,β
(t)
a
on P. After the five times of testing on allele
a, we denote y˜a,p = fP(t)a ,λ(t)a ,β(t)a (p) for each p ∈ Pa,t and t = 1, · · · , 5.
The RMSE score is therefore evaluated as
RMSEa =
√
1
#Pa
∑
p∈Pa
(y˜a,p − ya,p)
2
.
A smaller RMSE score indicates a better algorithm performance. Since the
affinity labels in this data set are transformed with ψb=50,000, there is a thresh-
old θ = ψ50,000(500) ≈ 0.4256 in [24] dividing the peptides p ∈ Pa into
“binding” if ya,p > θ and “non-binding” otherwise, to the allele a. Denote
Pa,B = {p ∈ Pa : ya,p > θ} and Pa,N = Pa\Pa,B. Then the AUC index is
defined to be
AUCa =
#{(p, p′) : p ∈ Pa,B, p
′ ∈ Pa,N , y˜a,p > y˜a,p′}
(#Pa,B) (#Pa,N )
∈ [0, 1]. (9)
The sequence of ideas for each allele a leads to Table 1. The computation
also suggests a weighted optimal values of β
β∗peptide :=
1∑
a#Pa
∑
a
{
(#Pa)
(
1
5
5∑
t=1
β(t)a
)}
= 0.11387. (10)
We will use this value in the next section.
3Both the data set and the 5-fold partition are available at http://www.cbs.dtu.dk/
suppl/immunology/NetMHCII-2.0.php.
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Remark 8. We take the point of view that peptide binding is a matter of
degree and hence is better measured by a real number, rather than the binding–
non-binding dichotomy. Thus RMSE is a better measure than AUC. The
results in Table 1 also demonstrate that the regression-based learning model
works well.
Remark 9. Our philosophy is that there is a kernel structure on the set of
amino acid sequences related to their biological functions (e.g. the correspon-
dent distances on peptides relates to their affinities to each allele). The kernel
should not depend on the alignment information, which is a source of noise.
The performance of our kernel Kˆ3 is reflected in the modulus of continuity
of the predicted values, namely,
Ωa := max
p,p′∈Pa
|y˜a,p − y˜a,p′|
d(p, p′)
,
where
d(p, p′) = ‖Kˆ3p − Kˆ
3
p′‖Kˆ3 =
√
2− 2Kˆ3(p, p′)
is the distance in the space HKˆ3 on peptides, and the kernel Kˆ
3 is defined
with β = β∗peptide. We list the values of Ωa for the 14 alleles in Table 2.
Allele a Ωa Allele a Ωa Allele a Ωa
DRB1*0101 1.2222 DRB1*0301 1.0307 DRB1*0401 0.9249
DRB1*0404 0.9726 DRB1*0405 0.8394 DRB1*0701 1.1317
DRB1*0802 0.9368 DRB1*0901 0.8004 DRB1*1101 0.9795
DRB1*1302 0.7745 DRB1*1501 0.9843 DRB3*0101 0.7395
DRB4*0101 0.8587 DRB5*0101 1.0011
Table 2: The module of continuity of the predicted values.
The modulus of continuity can be extended to a bigger peptide set P ′
which contains the neighbourhood of each peptide p ∈ P with respect to the
metric d.
3 Kernel Algorithm for pan-Allele Binding
Prediction
We now define a pan-allele kernel on the product space of alleles and peptides.
The binding affinity data is thus a subset of this product space. The main
motivation is that by the pan-allele kernel we predict affinities to those alleles
with few or no binding data available: this is often the case because the MHC
II alleles form a huge set (the phenomenon is often referred to as MHC II
polymorphism), and the job of determining experimentally peptide affinities
to all the alleles is immense. Also, in the pan-allele setting, one puts the
binding data to different alleles together to train the RLS. This makes the
training data set larger than that was available in the fixed allele setting, and
thus helps to improve the algorithm performance. This is verified in Table 4.
13
Let L be a finite set of amino acid sequences representing the MHC
II alleles. Using a positive parameter βallele we define a kernel Kˆ
3
L
on L
following the steps in the Introduction. Let P be a set of peptides. In
the sequel we denote by βpeptide specifically the parameter used to define the
kernel Kˆ3
P
on P. We define the pan-allele kernel on L ×P as
Kˆ3pan((a, p), (a
′, p′)) = Kˆ3L (a, a
′)Kˆ3P(p, p
′). (11)
Let be given a set of data {(pi, ai, ri)}
m
i=1. Then for each i, ai ∈ L , pi ∈ P,
and ri ∈ [0, 1] is the binding affinity of pi to ai. The RLS is applied as in
Section 2. The output function F : L × P → R is the predicted binding
affinity.
Remark 10. When we choose L = {a} for a certain allele a, the setting
and the algorithm reduce to the fixed-allele version studied in Section 2.
We test the pan-allele kernel with RLS (we call the algorithm “Kernel-
RLSPan”) on Nielsen’s NetMHCIIpan-2.0 data set (we also denote by this
name the algorithm published on [23] with the data set), which contains
33,931 peptide-allele pairs. For peptides, amino acid sequences are given,
and for alleles, DRB names are given so that we can find out the sequence
representations in N as defined in Section 1.2. Each pair is labeled with a
[0, 1]-valued binding affinity. There are 8083 peptides and 24 alleles in N in
total that appear in these peptide-allele pairs. The whole data set is divided
into 5 parts in [23]4.
We choose the following setting. Let L = N and P be a peptide set
large enough to contain all the peptides in the data set. We use β∗peptide =
0.11387 as suggested in (10) to construct Kˆ3
P
and leave the power index βallele
for Kˆ3
N
to be fixed later. This defines Kˆ3pan. We test the RLS algorithm by
five-fold cross validation according to the 5-part division in [23]. In each test
we merge 4 parts of the samples as the training data and leave the other
part as the testing data. Leave-one-out cross validation is further employed
in each test to tune the parameters. We select a pair (βallele, λ) from the
product of {0.02 × n : n = 1, 2, · · · , 8} and {en : n = −17,−16, · · · ,−9}.
The procedures are the same as used in Section 2.3 except we now do cross
validation for the peptide-allele pairs. In all the five tests, the pair βallele =
0.06 and λ = e−13 achieves the best performance in the training data. We
now use the threshold θ = ψ15,000(500) ≈ 0.3537 to evaluate the AUC score,
because the affinity values in the data set are obtained by the transform
ψ15,000. The results of these computations are shown in Table 3.
4Both the data set and the 5-part partition are available at http://www.cbs.dtu.dk/
suppl/immunology/NetMHCIIpan-2.0.
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allele, a #Pa
KernelRLS NetMHCIIpan-2.0
RMSE AUC AUC
DRB1*0101 7685 0.20575 0.84308 0.846
DRB1*0301 2505 0.18154 0.85095 0.864
DRB1*0302 148 0.21957 0.71176 0.757
DRB1*0401 3116 0.19860 0.84294 0.848
DRB1*0404 577 0.21887 0.80931 0.818
DRB1*0405 1582 0.17459 0.86862 0.858
DRB1*0701 1745 0.17769 0.87664 0.864
DRB1*0802 1520 0.18732 0.78937 0.780
DRB1*0806 118 0.23091 0.89214 0.924
DRB1*0813 1370 0.18132 0.88803 0.885
DRB1*0819 116 0.18823 0.82706 0.808
DRB1*0901 1520 0.19741 0.82220 0.818
DRB1*1101 1794 0.16022 0.88610 0.883
DRB1*1201 117 0.22740 0.87380 0.892
DRB1*1202 117 0.23322 0.89440 0.900
DRB1*1302 1580 0.19953 0.82298 0.825
DRB1*1402 118 0.20715 0.86474 0.860
DRB1*1404 30 0.18705 0.64732 0.737
DRB1*1412 116 0.26671 0.89967 0.894
DRB1*1501 1769 0.19609 0.82858 0.819
DRB3*0101 1501 0.15271 0.82921 0.85
DRB3*0301 160 0.26467 0.86857 0.853
DRB4*0101 1521 0.16355 0.87138 0.837
DRB5*0101 3106 0.18833 0.87720 0.882
Average 0.20035 0.84109 0.846
Weighted Average 0.19015 0.84887 0.849
Table 3: The performance of KernelRLSPan. For comparison we list the
AUC scores of NetMHCIIpan-2.0 [23]. The best AUC in each row is marked
in bold.
We implement KernelRLSPan on the fixed allele data set used in Table
1. Recall that the data set is normalized with ψ50,000 and has the five-fold
division defined by [25]. The performance is listed in Table 4, which is better
than that of KernelRLS as listed in Table 1.
allele, a RMSE AUC allele, a RMSE AUC
DRB1*0101 0.17650 0.86961 DRB1*0301 0.16984 0.85601
DRB1*0401 0.20970 0.82359 DRB1*0404 0.17240 0.88193
DRB1*0405 0.18425 0.84078 DRB1*0701 0.17998 0.90231
DRB1*0802 0.16734 0.88496 DRB1*0901 0.23562 0.71057
DRB1*1101 0.17073 0.91022 DRB1*1302 0.23261 0.75960
DRB1*1501 0.21266 0.80724 DRB3*0101 0.16011 0.79778
DRB4*0101 0.18751 0.84754 DRB5*0101 0.18904 0.89585
Average: RMSE 0.18916, AUC 0.84200
Weighted Average: RMSE 0.18496, AUC 0.85452
Table 4: The performance of KernelRLSPan on the fixed allele data. For
defining AUC, the transform ψ50,000 is used as in Table 1.
Next, we use the whole NetMHCIIpan-2.0 data set for training, and test
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the algorithm performance on a new data set. A set of 64798 triples of MHC
II-peptide binding data is downloaded from IEDB5. We pick from the set the
DRB alleles, having IC50 scores, and having explicit allele names and peptide
sequences. Those items that also appear in the NetMHCIIpan-2.0 data set
are deleted. For the duplicated items (same peptide-allele pair and same
affinity) only one of them are kept. All the pieces with the same peptide-
allele pair yet different affinities are deleted. We deleted those with peptide
length less than 9. (The KernelRLSPan can handle these peptides, while
the NetMHCIIpan-2.0 cannot. The short peptides therefore are deleted to
make the two algorithms comparable.) For some alleles the data in the set
is insufficient to define the AUC score (i.e. the denominator in (9) becomes
zero), so we delete tuples containing them. Eventually we obtained 11334
peptide-allele pairs labelled with IC50 binding affinities, which are further
normalized by ψ15,000 as in the NetMHCIIpan-2.0 data set.
Now define Kˆ3pan on N ×P as in (11) with βallele = 0.06 as suggested by
the above computation and βpeptide = 0.11387 as suggested in (10). We train
on the NetMHCIIpan-2.0 data set both KernelRLSPan and NetMHCIIpan-
2.06. In the KernelRLSPan, leave-one-out cross validation is used to select
λ from {e−18, · · · , e−8} (the result shows that λ = e−13 performs the best).
The algorithm performance of the two algorithms are compared on Table 5.
5 The data set was downloaded from http://www.immuneepitope.org/list page.php?
list type=mhc&measured response=&total rows=64797&queryType=true, on May 23,
2012.
6 The code is published on http://www.cbs.dtu.dk/cgi-bin/nph-sw request?netMHCIIpan.
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allele, a #Pa
kernelRLSpan NetMHCIIpan-2.0
RMSE AUC RMSE AUC
DRB1*0101 1024 0.25519 0.79717 0.24726 0.82988
DRB1*0102 7 0.39748 0.58333 0.62935 0.58333
DRB1*0103 41 0.33159 0.83333 0.32204 0.83333
DRB1*0301 883 0.21760 0.80276 0.23975 0.82384
DRB1*0401 1122 0.19610 0.79930 0.19363 0.82456
DRB1*0402 48 0.23912 0.67321 0.27352 0.65714
DRB1*0403 43 0.16381 0.70443 0.15868 0.66995
DRB1*0404 494 0.21689 0.79344 0.20219 0.82517
DRB1*0405 462 0.19617 0.78941 0.19387 0.80611
DRB1*0406 14 0.19516 0.53846 0.19497 0.61538
DRB1*0701 724 0.20853 0.80876 0.20039 0.84786
DRB1*0801 24 0.37281 0.72500 0.34767 0.71250
DRB1*0802 404 0.17403 0.80407 0.17181 0.81085
DRB1*0901 335 0.21204 0.79524 0.21029 0.80489
DRB1*1001 20 0.28082 0.74000 0.24335 0.92000
DRB1*1101 811 0.24195 0.83219 0.23838 0.85071
DRB1*1104 10 0.43717 0.76190 0.57082 0.57143
DRB1*1201 795 0.25786 0.83178 0.24984 0.82685
DRB1*1301 147 0.27014 0.65077 0.30202 0.70722
DRB1*1302 499 0.22194 0.82118 0.21284 0.84258
DRB1*1501 856 0.21580 0.83563 0.20869 0.84902
DRB1*1502 3 0.13186 1.00000 0.20061 1.00000
DRB1*1601 16 0.19556 0.84615 0.18740 0.76923
DRB1*1602 12 0.32238 0.68571 0.30431 0.60000
DRB3*0101 437 0.16568 0.74058 0.17860 0.77182
DRB3*0202 750 0.16021 0.82543 0.16453 0.84191
DRB4*0101 563 0.20594 0.80575 0.21383 0.78734
DRB5*0101 774 0.25934 0.78701 0.25849 0.81950
DRB5*0202 16 0.23013 0.71429 0.40554 0.57143
Average 0.24046 0.76987 0.25947 0.77151
Weighted Average 0.21853 0.80309 0.21816 0.82216
Table 5: The performance of KernelRLSPan and NetMHCIIpan-2.0 trained
on the NetMHCIIpan-2.0 benchmark data set, tested on a new dataset down-
loaded from the IEDB. The best performance of both AUC and RMSE scores
of each row is marked in bold.
In this section KernelRLSPan is tested. Tables 3, 4 and 5 suggest that
compared with KernelRLS, KernelRLSPan performs much better. Also, the
kernel method uses only the substitution matrix and the sequence represen-
tations without direct alignment information but yields comparable perfor-
mance with the state-of-the-art NetMHCIIpan-2.0 algorithm.
4 Clustering and Supertypes
In this section, we describe in detail the construction of our cluster tree and
our classification of DRB alleles into supertypes. We compare the supertypes
identified by our model with the serotypes designated by WHO and analyze
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the comparison results in detail.
4.1 Identification of DRB Supertypes
We classify DRB alleles into disjoint subsets by using DRB amino acid se-
quences and the BLOSUM62 substitution matrix. No peptide binding data
or X-ray 3D structure data are used in our clustering. We obtain a classifi-
cation in this way into subsets (a partition) which we call supertypes.
In Section 3, we have defined the allele kernel on N as Kˆ3
N
; the L2
distance derived from Kˆ3
N
is defined as
DL2(x, y) =
(
1
#N
∑
z∈N
(
Kˆ3(x, z)− Kˆ3(y, z)
)2)1/2
, ∀x, y ∈ N .
The OWA-based linkage, defined as follows is used to measure the proxim-
ity between clustersX and Y 7. Let U = (dxy)x∈X,y∈Y , where dxy = DL2(x, y).
After ordering (with repetitions) the elements of U in descending order, we
obtain an ordered vector V = (d′1, . . . , d
′
n), n = |U |. A weighting vector
W = (w1, · · · , wn) is associated with V , and the proximity between clusters
X and Y is defined as
DOWA(X, Y ) =
n∑
i=1
wid
′
i.
Here the weights W are defined as follows [28]:
w′i =
ei/µ
µ
, i = 1, 2, · · · , n,
wi =
w′i∑n
j=1w
′
j
, i = 1, 2, · · · , n,
where µ = γ(1 + n) and γ is chosen appropriately as 0.1. This weighting
gives more importance to pairs (x, y) which have smaller distance.
Hierarchical clustering [6] is applied to build a cluster tree. A cluster tree
is a tree on which every node represents the cluster of the set of all leaves
descending from that node. The L2 distance DL2 is used to measure the
distance between alleles x and y, x, y ∈ M and OWA-based linkage is used
to measure the proximity between clusters X and Y , X, Y ⊆ M instead of
“single” linkage. This algorithm is a bottom-up approach. At the beginning,
each allele is treated as a singleton cluster, and then successively one merges
two nearest clusters X and Y into a union cluster, the process stopping when
all unions of clusters have been merged into a single cluster.
This cluster tree, associated to M , has thus 559 leaves. We cut the
cluster tree at 16 clusters, an appropriate level to separate different families
of alleles. The upper part of this tree is shown in Figure 1. The contents of
the clusters are given in Table 6. We assign supertypes to certain clusters in
the cluster tree based on the contents of the clusters described in Table 6. A
supertype is based on one or two clusters in Table 6. If two clusters in Table
6 are closest in the tree, and the alleles in which are in the same family, they
7Another way of measuring distance between clusters is the Hausdorff distance.
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are assigned an identical supertype. Thirteen supertypes are defined in this
way, which we name ST1, ST2, ST3, ST4, ST5, ST6, ST7, ST8, ST9, ST10,
ST51, ST52 and ST53. The corresponding cluster diameters are 0.11, 0.13,
0.15, 0.14, 0.11, 0.18, 0.08, 0.14, 0.08, 0.02, 0.09, 0.13 and 0.05, respectively.
The diameter of a cluster Z is defined as
diameter(Z) = max
x,y∈Z
DL2(x, y). (12)
The DRB alleles in the first ten supertypes are gathered from the DRB1
locus. The DRB alleles in the ST51, ST52 and ST53 supertypes are gathered
from the DRB5 , DRB3 and DRB4 loci, respectively.
4.2 Serotype designation of HLA-DRB alleles
There is a historically developed classification, based on extensive works
of medical labs and organizations, that groups alleles into what are called
serotypes. This classification is oriented to immunology and diseases associ-
ated to gene variation in humans. It uses peptide binding data, 3D structure,
X-ray diffraction and other tools. When the confidence level is sufficiently
high, WHO assigns a serotype to an allele as in Table 6 where a number
prefixed by DR follows the name of that allele.
There are four DRB genes (DRB1/DRB3/DRB4/DRB5) in the HLA-
DRB region [16]. The DRB1 gene/locus is much more polymorphic than
the DRB3/DRB4/DRB5 genes/loci [3]. More than 800 allelic variants are
derived from the exon 2 of the DRB genes in humans [9]. The WHO Nomen-
clature Committee for Factors of the HLA System assigns an official name for
each identified allele sequence, e.g. DRB1*01:01. The characters before the
separator “*” describe the name of the gene, the first two digits correspond
to the allele family and the third and fourth digits correspond to a specific
HLA protein. See Table 6 for examples of how the alleles are named. If two
HLA alleles belong to the same family, they often correspond to the same
serological antigen, and thus the first two digits are meant to suggest sero-
logical types. So for those alleles which are not assigned serotypes by WHO,
WHO has suggested serotypes for them according to their official names or
allele families.
4.3 Comparison of identified supertypes to designated
serotypes
In Section 4.1, we have identified thirteen supertypes and in Section 4.2 we
have introduced the WHO assigned serotypes. In the following, we compare
these two classifications.
By using the cluster tree given in Figure 1 and the contents of the clusters
described in Table 6, we have named our supertypes with prefix “ST” par-
alleled to the serotype names. The detailed information of DRB alleles and
serological types for these 13 supertypes is given in Table 6. Our supertype
clustering recovers the WHO serotype classification and provides further in-
sight into the classification of DRB alleles which are not assigned serotypes.
There are 559 DRB alleles in Table 6, and only 138 DRB alleles have WHO
assigned serotypes. Table 7 gives the relationship between the broad sero-
logical types and the split serological types. As shown in Tables 6 and 7,
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our supertypes assigned to these 138 DRB alleles are in exact agreement
with the WHO assigned broad serological types (see Table 7). Extensive
medical/biological information was used by WHO to assign serological type
whereas solely DRB amino acid sequences were used in our supertype clus-
tering. All alleles with WHO assigned DR52, DR3, DR6, DR8, DR4, DR2,
DR5, DR53, DR9, DR7, DR51, DR10 and DR1-serotype are classified, re-
spectively, into the ST52, ST3, ST6, ST8, ST4, ST2, ST5, ST53, ST9, ST7,
ST51, ST10 and ST1-supertype. The other 461 alleles in Table 6 are not
assigned serotypes by WHO in [14]. However, WHO has suggested serotypes
for them according to their official names or allele families; that is, if two
DRB alleles are in the same family, they belong to the same serotype. Our
clustering confirms that this suggestion is reasonable, as can be checked from
the clusters in Table 6.
We make some remarks on Figure 1 and Table 6 as follows.
ST52: This supertype consists of exactly the DRB3 alleles with the ex-
ception of DRB1*0338 (a new allele and unassigned by WHO [14]).
ST3: This supertype consists of cluster 2 and cluster 3 in the cluster
tree and contains 63 DRB1*03 alleles with two exceptions: DRB3*0115 and
DRB1*1525. The DRB3*0115 is grouped with the DRB1*03 alleles in a
number of different experiments done by us, and the DRB1*1525 is a new
allele and unassigned by WHO. Here, the DR3-serotype is a broad serotype
which consists of three split serotypes, DR3, DR17 and DR18 (see Table 7).
ST6: This supertype consists of cluster 4 and cluster 5 and consists of ex-
actly 102 DRB1*14 alleles. Here, the DR6-serotype is a broad serotype which
consists of five split serotypes, DR6, DR13, DR14, DR1403 and DR1404.
ST8: This supertype consists of cluster 6 and cluster 7 and mainly con-
tains 46 DRB1*08 alleles (The serological designation of DRB1*1415 is DR8
by WHO.). The unassigned alleles DRB1*1425, DRB1*1440, DRB1*1442,
DRB1*1469, DRB1*1477 and DRB1*1484 are DRB1*14 alleles, but they are
classified into the ST8 supertype. Both DRB1*14116 and DRB1*14102 are
new allele sequences that do not exist in the tables of [14, 22] and they are
classified into the ST8 supertype too.
Supertypes 52, 4, 2, 5, 53, 9, 7, 51, 10 and 1 correspond, respectively, to
clusters 1, 8, 9, 10, 11, 12, 13, 14, 15 and 16 in the cluster tree.
ST4: This supertype consists of exactly 99 DRB1*04 alleles.
ST2: This supertype consists of 53 DRB1*15 alleles and 16 DRB1*16
alleles. Here, the DR2-serotype is a broad serotype which consists of three
split serotypes, DR2, DR15 and DR16.
ST5: This supertype contains exactly 29 DRB1*12 alleles. The DRB1*0832
is undefined by experts in [14], but its serological designation by the neural
network algorithm [21] is DR8 or DR12. We classify it into the ST5 su-
pertype. The DR5-serotype is a broad serotype which consists of two split
serotypes, DR11 and DR12.
ST53: This supertype consists of exactly the DRB4 alleles.
ST9: This supertype contains exactly the DRB1*09 alleles with the ex-
ception of DRB5*0112. The DRB5*0112 is undefined by experts in [14]. And
from a number of different experiments done by us, DRB5*0112 is clustered
with the DRB1*09 family of alleles.
ST7: This supertype consists of exactly 19 DRB1*07 alleles.
ST51: This supertype consists of exactly 15 DRB5 alleles.
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ST10: This supertype is the smallest supertype and consists of exactly 3
DRB1*10 alleles.
ST1: This supertype consists of exactly 36 DRB1*01 alleles. Here, the
DR1-serotype is a broad serotype which consists of two split serotypes, DR1
and DR103.
For the DRB alleles, there are thirteen broad serotypes given by WHO,
and our clustering classifies all alleles which are assigned the same broad
serotype to the same supertype. And for the alleles which are not assigned
serotypes, our supertypes confirm the nomenclature of WHO.
As can be seen from Figure 1, the ST52 supertype is closest to the ST3
supertype. The ST53 supertype is closest to the ST9 and ST7 supertypes.
The ST51 supertype is closest to the ST10 and ST1 supertypes.
4.4 Previous work in perspective
In 1999, Sette and Sidney asserted that all HLA I alleles can be classified
into nine supertypes [34, 37]. This classification is defined based on the
structural motifs derived from experimentally determined binding data. The
alleles in the same supertype comprise the same peptide binding motifs and
bind to largely overlapping sets of peptides. Essentially, the supertype clas-
sification problem is to identify peptides that can bind to a group of HLA
molecules. Besides many works on HLA class I supertype classification, some
works have been proposed to identify supertypes for HLA class II. In 1998,
through analyzing a large set of biochemical synthetic peptides and a panel of
HLA-DR binding assays, Southwood et al. [39] asserted that seven common
HLA-DR alleles, e.g. DRB1*0101, DRB1*0401, DRB1*0701, DRB1*0901,
DRB1*1302, DRB1*1501 and DRB5*0101 had similar peptide binding speci-
ficity and should be grouped into one supertype. By the use of HLA ligands,
Lund et al. [19] clustered 50 DRB alleles into nine supertypes by a Gibbs
Sampling algorithm. Both of these studies used peptide binding data and
this resulted in the limited number of DRB alleles available for classification.
The work of Doytchinova and Flower [7], classified 347 DRB alleles into 5
supertypes by the use of both protein sequences and 3D structural data. Ou
et al. [26]. defined seven supertypes based on similarity of function rather
than on sequence or structure. To our knowledge, our study is the first to
identify HLA-DR supertypes solely based on DRB amino acid sequence data.
Super- Allele Sero- Allele Sero- Allele Sero-
type type type type
ST52 Cluster 1
DRB3*0101(2) DR52 DRB3*0108(U.) – DRB3*0212(U.) –
DRB3*0106(s.s.) DR52 DRB3*0102(s.s.) – DRB3*0226 –
DRB3*0110(s.s.) DR52 DRB3*0112 – DRB3*0222(U.) –
DRB3*0301 DR52 DRB3*0105(U.) – DRB3*0204(U.) –
DRB3*0209 DR52 DRB3*0103(s.s.)(U.) – DRB3*0213(U.) –
DRB3*0302(s.s.) DR52 DRB3*0113 – DRB3*0215(U.) –
DRB3*0107(s.s.) DR52 DRB3*0111(U.) – DRB3*0218(U.) –
DRB3*0203(s.s.) DR52 DRB3*0114 – DRB3*0205(U.) –
DRB3*0211 DR52 DRB3*0303 – DRB3*0225 –
DRB3*0201(2) DR52 DRB3*0109(U.) – DRB3*0219(U.) –
DRB3*0202(2) DR52 DRB3*0206(s.s.) – DRB3*0216(U.) –
DRB3*0210 DR52 DRB3*0220(U.) – DRB3*0221(U.) –
DRB3*0208(s.s.) DR52 DRB3*0223 – DRB3*0227 –
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DRB3*0207(s.s.) DR52 DRB3*0217(U.) –
DRB1*0338 – DRB3*0214(U.) –
ST3 Cluster 2
DRB1*0323 DR3 DRB1*0334 – DRB1*0358 –
DRB1*0301(2) DR17 DRB1*0364 – DRB1*0308 –
DRB1*0305 DR3 DRB1*0361 – DRB1*0326 –
DRB1*0311 DR17 DRB1*0332 – DRB1*0313 –
DRB1*0304 DR17 DRB1*0328 – DRB1*0360 –
DRB1*0306 DR3 DRB1*0362 – DRB1*0324 –
DRB1*0307 DR3 DRB1*0346 – DRB1*0352 –
DRB1*0314 DR3 DRB1*0336 – DRB1*0365 –
DRB1*0315 DR3 DRB1*0357 – DRB1*0329 –
DRB1*0312(s.s.) DR3 DRB1*0339 – DRB1*0327 –
DRB1*0302 DR18 DRB1*0333 – DRB1*0353 –
DRB1*0303 DR18 DRB1*0319 – DRB1*0321 –
DRB1*0310 DR17 DRB1*0348 – DRB1*0343 –
DRB1*0342 – DRB1*0363 – DRB1*0330 –
DRB1*0345 – DRB1*0322 – DRB1*0325 –
DRB1*0355 – DRB1*0309 – DRB1*0344 –
DRB1*0359 – DRB1*0337 – DRB1*0331 –
DRB1*0354 – DRB1*0351 – DRB1*0335 –
DRB1*0320 – DRB1*0347 – DRB3*0115 –
DRB1*0356 – DRB1*0318 – DRB1*0316(s.s.) –
Cluster 3
DRB1*1525 – DRB1*0340 – DRB1*0317 –
DRB1*0349 – DRB1*0341 –
ST6 Cluster 4
DRB1*1410 DR14 DRB1*1482 – DRB1*1472 –
DRB1*1401(4) DR14 DRB1*1462 – DRB1*14101 –
DRB1*1426 DR14 DRB1*1470 – DRB1*1434 –
DRB1*1407 DR14 DRB1*1438 – DRB1*1423 –
DRB1*1460 DR14 DRB1*14112 – DRB1*1445 –
DRB1*1450 DR14 DRB1*1490 – DRB1*1443 –
DRB1*1404 DR1404 DRB1*1486 – DRB1*1456 –
DRB1*1449 DR14 DRB1*1497 – DRB1*14103 –
DRB1*1411 DR14 DRB1*1435 – DRB1*1444 –
DRB1*1408 DR14 DRB1*1455 – DRB1*1496 –
DRB1*1414 DR14 DRB1*1431 – DRB1*14100 –
DRB1*1405 DR14 DRB1*1493 – DRB1*1436 –
DRB1*1420 DR14 DRB1*1428 – DRB1*1465 –
DRB1*1422 DR14 DRB1*1471 – DRB1*1464 –
DRB1*1416 DR6 DRB1*1468 – DRB1*1495 –
DRB1*1439 – DRB1*1432 – DRB1*1459 –
DRB1*1499 – DRB1*14111 – DRB1*1491 –
DRB1*1461 – DRB1*14104 – DRB1*1441 –
DRB1*14117 – DRB1*1458 – DRB1*1437 –
DRB1*1487 – DRB1*1473 – DRB1*1457 –
DRB1*1475 – DRB1*1479 – DRB1*14105 –
DRB1*1488 – DRB1*14107 – DRB1*1474 –
DRB1*14110 – DRB1*1476 –
Cluster 5
DRB1*1419 DR14 DRB1*1452 – DRB1*1433 –
DRB1*1402 DR14 DRB1*14108 – DRB1*1424 –
DRB1*1429 DR14 DRB1*1483 – DRB1*14109 –
DRB1*1406 DR14 DRB1*1481 – DRB1*14115 –
DRB1*1418 DR6 DRB1*1494 – DRB1*1467 –
DRB1*1413 DR14 DRB1*1447 – DRB1*1498 –
DRB1*1421 DR14 DRB1*1451 – DRB1*1463 –
DRB1*1417 DR6 DRB1*14106 – DRB1*1485 –
DRB1*1427 DR14 DRB1*1489 – DRB1*1478 –
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DRB1*1403 DR1403 DRB1*1430 – DRB1*1448 –
DRB1*1412 DR14 DRB1*1409 –
DRB1*1446 – DRB1*1480 –
ST8 Cluster 6
DRB1*1442(U.) –
Cluster 7
DRB1*0809 DR8 DRB1*1477 – DRB1*0808 –
DRB1*1415 DR8 DRB1*1440 – DRB1*0844 –
DRB1*0814 DR8 DRB1*1484 – DRB1*0835 –
DRB1*0812 DR8 DRB1*0846 – DRB1*0836 –
DRB1*0803 DR8 DRB1*0848 – DRB1*0847 –
DRB1*0810 DR8 DRB1*0819 – DRB1*0825 –
DRB1*0817 DR8 DRB1*0827 – DRB1*0834 –
DRB1*0811 DR8 DRB1*0829 – DRB1*0828 –
DRB1*0801 DR8 DRB1*0837 – DRB1*0845 –
DRB1*0807 DR8 DRB1*0839 – DRB1*0830 –
DRB1*0806 DR8 DRB1*0822 – DRB1*0824 –
DRB1*0805 DR8 DRB1*0815 – DRB1*0820(U.) –
DRB1*0818 DR8 DRB1*0840 – DRB1*14116 –
DRB1*0816 DR8 DRB1*0838 – DRB1*14102 –
DRB1*0802 DR8 DRB1*0826 – DRB1*0842 –
DRB1*0804 DR8 DRB1*0843 – DRB1*0841 –
DRB1*0813 DR8 DRB1*0833 – DRB1*1425 –
DRB1*0821 – DRB1*0823 – DRB1*1469 –
ST4 Cluster 8
DRB1*0420(s.s.) DR4 DRB1*0438 – DRB1*0490 –
DRB1*0401 DR4 DRB1*0434 – DRB1*0487 –
DRB1*0464 DR4 DRB1*0475 – DRB1*0430 –
DRB1*0408 DR4 DRB1*0476 – DRB1*0448 –
DRB1*0416 DR4 DRB1*0472 – DRB1*0467 –
DRB1*0426 DR4 DRB1*0435 – DRB1*0483 –
DRB1*0442 DR4 DRB1*0443 – DRB1*0480 –
DRB1*0432(s.s.) DR4 DRB1*0479 – DRB1*0462 –
DRB1*0423 DR4 DRB1*0440 – DRB1*0457 –
DRB1*0404 DR4 DRB1*0470 – DRB1*0497 –
DRB1*0413 DR4 DRB1*0444 – DRB1*0463 –
DRB1*0431 DR4 DRB1*0456 – DRB1*0498 –
DRB1*0403 DR4 DRB1*0455 – DRB1*0449 –
DRB1*0407(2) DR4 DRB1*0433 – DRB1*04102 –
DRB1*0429 DR4 DRB1*0439 – DRB1*0441 –
DRB1*0424 DR4 DRB1*0460 – DRB1*0446 –
DRB1*0409 DR4 DRB1*0450 – DRB1*0485 –
DRB1*0405 DR4 DRB1*0496 – DRB1*0478 –
DRB1*0410 DR4 DRB1*0451 – DRB1*0465 –
DRB1*0428 DR4 DRB1*0471 – DRB1*0491 –
DRB1*0417 DR4 DRB1*04100 – DRB1*0468 –
DRB1*0411 DR4 DRB1*0488 – DRB1*0477 –
DRB1*0422 DR4 DRB1*0493 – DRB1*0484 –
DRB1*0406 DR4 DRB1*0427 – DRB1*0447 –
DRB1*0421 DR4 DRB1*0452 – DRB1*0436 –
DRB1*0419 DR4 DRB1*04101 – DRB1*0454 –
DRB1*0425(s.s.) DR4 DRB1*0474 – DRB1*0437 –
DRB1*0414 DR4 DRB1*0495 – DRB1*0453 –
DRB1*0402 DR4 DRB1*0459 – DRB1*0418 –
DRB1*0415 DR4 DRB1*0473 – DRB1*0458 –
DRB1*0499 – DRB1*0461 – DRB1*0486 –
DRB1*0482 – DRB1*0445 – DRB1*0412 –
DRB1*0466 – DRB1*0489 – DRB1*0469 –
ST2 Cluster 9
DRB1*1501(2) DR15 DRB1*1533 – DRB1*1548 –
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DRB1*1505 DR15 DRB1*1553 – DRB1*1512 –
DRB1*1506 DR15 DRB1*1524 – DRB1*1515 –
DRB1*1503 DR15 DRB1*1509 – DRB1*1557 –
DRB1*1508 DR2 DRB1*1549 – DRB1*1511 –
DRB1*1502(2) DR15 DRB1*1541 – DRB1*1538 –
DRB1*1504 DR15 DRB1*1540 – DRB1*1529 –
DRB1*1507 DR15 DRB1*1523 – DRB1*1545 –
DRB1*1602 DR16 DRB1*1518 – DRB1*1554 –
DRB1*1605(s.s.) DR16 DRB1*1537 – DRB1*1510 –
DRB1*1601 DR16 DRB1*1514 – DRB1*1521 –
DRB1*1609 DR16 DRB1*1544 – DRB1*1612 –
DRB1*1603 DR2 DRB1*1526 – DRB1*1617 –
DRB1*1604 DR16 DRB1*1539 – DRB1*1611 –
DRB1*1528 – DRB1*1530 – DRB1*1614 –
DRB1*1535 – DRB1*1531 – DRB1*1618 –
DRB1*1532 – DRB1*1556 – DRB1*1610 –
DRB1*1542 – DRB1*1555 – DRB1*1608 –
DRB1*1551 – DRB1*1516 – DRB1*1615 –
DRB1*1552 – DRB1*1522 – DRB1*1607 –
DRB1*1536 – DRB1*1546 – DRB1*1616 –
DRB1*1520 – DRB1*1547 – DRB1*1527 –
DRB1*1543 – DRB1*1558 – DRB1*1534 –
ST5 Cluster 10
DRB1*1202 DR12 DRB1*1215 – DRB1*1230 –
DRB1*1201(4) DR12 DRB1*1219 – DRB1*1207 –
DRB1*1203 DR12 DRB1*1216 – DRB1*1229 –
DRB1*1205 DR12 DRB1*1221 – DRB1*1234 –
DRB1*1220 – DRB1*1208 – DRB1*1222 –
DRB1*1233 – DRB1*1212 – DRB1*1223 –
DRB1*1218 – DRB1*1225 – DRB1*1227 –
DRB1*1213 – DRB1*1211 – DRB1*1209 –
DRB1*1232 – DRB1*1228 – DRB1*1204 –
DRB1*1226 – DRB1*1214 – DRB1*0832(U.) –
ST53 Cluster 11
DRB4*0101(3) DR53 DRB4*0104(U.) – DRB4*0107(U.) –
DRB4*0105(s.s.) DR53 DRB4*0102(s.s.)(U.) – DRB4*0108 –
ST9 Cluster 12
DRB1*0901 DR9 DRB1*0912 – DRB1*0915 –
DRB1*0905 DR9 DRB1*0906 – DRB1*0911 –
DRB1*0910 – DRB1*0908 – DRB1*0914 –
DRB1*0916 – DRB1*0904 – DRB5*0112(U.) –
DRB1*0907 – DRB1*0903 – DRB1*0902 –
DRB1*0909 – DRB1*0913 –
ST7 Cluster 13
DRB1*0703 DR7 DRB1*0721 – DRB1*0708 –
DRB1*0701 DR7 DRB1*0716 – DRB1*0711 –
DRB1*0709 DR7 DRB1*0713 – DRB1*0717 –
DRB1*0704 DR7 DRB1*0714 – DRB1*0707 –
DRB1*0715 – DRB1*0712 – DRB1*0706 –
DRB1*0719 – DRB1*0720 –
DRB1*0705 – DRB1*0718 –
ST51 Cluster 14
DRB5*0101 DR51 DRB5*0104(U.) – DRB5*0106(U.) –
DRB5*0102 DR51 DRB5*0103(U.) – DRB5*0111(U.) –
DRB5*0107(s.s.) DR51 DRB5*0113(U.) – DRB5*0204(U.) –
DRB5*0202 DR51 DRB5*0109(s.s.)(U.) – DRB5*0203(U.) –
DRB5*0105(U.) – DRB5*0114 – DRB5*0205(U.) –
ST10 Cluster 15
DRB1*1001 DR10 DRB1*1003 – DRB1*1002 –
ST1 Cluster 16
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DRB1*0107 DR1 DRB1*0120 – DRB1*0135 –
DRB1*0101 DR1 DRB1*0127 – DRB1*0111 –
DRB1*0102 DR1 DRB1*0112 – DRB1*0117 –
DRB1*0104 DR1 DRB1*0128 – DRB1*0118 –
DRB1*0109 DR1 DRB1*0136 – DRB1*0115 –
DRB1*0103 DR103 DRB1*0131 – DRB1*0106 –
DRB1*0113 DR1 DRB1*0132 – DRB1*0126 –
DRB1*0122 – DRB1*0119 – DRB1*0137 –
DRB1*0124 – DRB1*0130 – DRB1*0123 –
DRB1*0110 – DRB1*0121 – DRB1*0108 –
DRB1*0129 – DRB1*0105 – DRB1*0114 –
DRB1*0134 – DRB1*0125 – DRB1*0116 –
Table 6: Overview of clusters of HLA-DR alleles with split sero-
logical types assigned by WHO.
The split serological types are obtained from [14]. The left column indicates
the supertypes defined by the cluster tree. Remark on the labels for the
alleles: “(U.)” stands for “undefined” marked by the experts in [14]; “(s.s.)”
indicates that the normal forms of the allele is shorter than 81 amino acids;
“(n)” with n = 2, 3, · · · indicates that the normal form is shared by n alleles.
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HLA-DRB1 serological families
Broad Serotype Split serotype Alleles
DR1
DR1 DRB1*01
DR103 DRB1*0103
DR2
DR2 DRB1*1508, *1603
DR15 DRB1*15
DR16 DRB1*16
DR3
DR3 DRB1*0305, *0306, *0307,
*0312, *0314, *0315, *0323
DR17 DRB1*0301, *0304, *0310, *0311
DR18 DRB1*0302, *0303
DR4 DR4 DRB1*04
DR5
DR11 DRB1*11
DR12 DRB1*12
DR6
DR6 DRB1*1416, *1417, *1418
DR13 DRB1*13, *1453
DR14 DRB1*14, *1354
DR1403 DRB1*1403
DR1404 DRB1*1404
DR7 DR7 DRB1*07
DR8 DR8 DRB1*08, *1415
DR9 DR9 DRB1*09
DR10 DR10 DRB1*10
DRB3/4/5 serological families
Serotype Alleles
DR51 DRB5*01,02
DR52 DRB3*01,02,03
DR53 DRB4*01
Table 7: Overview of the broad serological types in connection with the split
serological types assigned by WHO. The serological type information listed
in this table was extracted from the Tables 4 and 5 given in [14]. This table
summarizes the allele and serotype information given in the first and third
columns of Tables 4 and 5.
We are far from claiming to have any definitive answers or final state-
ments on these questions of peptide binding and serotype clustering. Many
problems here are left unresolved. For example, the serotype clustering re-
sult is more provocative than otherwise and further studies are needed. One
could look at more automatic choice of the supertypes, or develop compara-
tive schemes. One could also study problems of phylogenetic trees from this
point of view as those of H5N1. Extending the framework to 3D structures of
proteins, instead of just amino acid chains is suggested. We intend to study
these questions ourselves and hope that our study will persuade others to
think about these kernels on amino acid chains.
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Appendix
A The BLOSUM62-2 Matrix
We list the whole BLOSUM62-2 matrix in Table 8. Table 9 explains the
amino acids denoted by the capital letters.
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A R N D C Q E G H I
A 3.9029 0.6127 0.5883 0.5446 0.8680 0.7568 0.7413 1.0569 0.5694 0.6325
R 0.6127 6.6656 0.8586 0.5732 0.3089 1.4058 0.9608 0.4500 0.9170 0.3548
N 0.5883 0.8586 7.0941 1.5539 0.3978 1.0006 0.9113 0.8637 1.2220 0.3279
D 0.5446 0.5732 1.5539 7.3979 0.3015 0.8971 1.6878 0.6343 0.6786 0.3390
C 0.8680 0.3089 0.3978 0.3015 19.5766 0.3658 0.2859 0.4204 0.3550 0.6535
Q 0.7568 1.4058 1.0006 0.8971 0.3658 6.2444 1.9017 0.5386 1.1680 0.3829
E 0.7413 0.9608 0.9113 1.6878 0.2859 1.9017 5.4695 0.4813 0.9600 0.3305
G 1.0569 0.4500 0.8637 0.6343 0.4204 0.5386 0.4813 6.8763 0.4930 0.2750
H 0.5694 0.9170 1.2220 0.6786 0.3550 1.1680 0.9600 0.4930 13.5060 0.3263
I 0.6325 0.3548 0.3279 0.3390 0.6535 0.3829 0.3305 0.2750 0.3263 3.9979
L 0.6019 0.4739 0.3100 0.2866 0.6423 0.4773 0.3729 0.2845 0.3807 1.6944
K 0.7754 2.0768 0.9398 0.7841 0.3491 1.5543 1.3083 0.5889 0.7789 0.3964
M 0.7232 0.6226 0.4745 0.3465 0.6114 0.8643 0.5003 0.3955 0.5841 1.4777
F 0.4649 0.3807 0.3543 0.2990 0.4390 0.3340 0.3307 0.3406 0.6520 0.9458
P 0.7541 0.4815 0.4999 0.5987 0.3796 0.6413 0.6792 0.4774 0.4729 0.3847
S 1.4721 0.7672 1.2315 0.9135 0.7384 0.9656 0.9504 0.9036 0.7367 0.4432
T 0.9844 0.6778 0.9842 0.6948 0.7406 0.7913 0.7414 0.5793 0.5575 0.7798
W 0.4165 0.3951 0.2778 0.2321 0.4500 0.5094 0.3743 0.4217 0.4441 0.4089
Y 0.5426 0.5560 0.4860 0.3457 0.4342 0.6111 0.4965 0.3487 1.7979 0.6304
V 0.9365 0.4201 0.3690 0.3365 0.7558 0.4668 0.4289 0.3370 0.3394 2.4175
L K M F P S T W Y V
A 0.6019 0.7754 0.7232 0.4649 0.7541 1.4721 0.9844 0.4165 0.5426 0.9365
R 0.4739 2.0768 0.6226 0.3807 0.4815 0.7672 0.6778 0.3951 0.5560 0.4201
N 0.3100 0.9398 0.4745 0.3543 0.4999 1.2315 0.9842 0.2778 0.4860 0.3690
D 0.2866 0.7841 0.3465 0.2990 0.5987 0.9135 0.6948 0.2321 0.3457 0.3365
C 0.6423 0.3491 0.6114 0.4390 0.3796 0.7384 0.7406 0.4500 0.4342 0.7558
Q 0.4773 1.5543 0.8643 0.3340 0.6413 0.9656 0.7913 0.5094 0.6111 0.4668
E 0.3729 1.3083 0.5003 0.3307 0.6792 0.9504 0.7414 0.3743 0.4965 0.4289
G 0.2845 0.5889 0.3955 0.3406 0.4774 0.9036 0.5793 0.4217 0.3487 0.3370
H 0.3807 0.7789 0.5841 0.6520 0.4729 0.7367 0.5575 0.4441 1.7979 0.3394
I 1.6944 0.3964 1.4777 0.9458 0.3847 0.4432 0.7798 0.4089 0.6304 2.4175
L 3.7966 0.4283 1.9943 1.1546 0.3711 0.4289 0.6603 0.5680 0.6921 1.3142
K 0.4283 4.7643 0.6253 0.3440 0.7038 0.9319 0.7929 0.3589 0.5322 0.4565
M 1.9943 0.6253 6.4815 1.0044 0.4239 0.5986 0.7938 0.6103 0.7084 1.2689
F 1.1546 0.3440 1.0044 8.1288 0.2874 0.4400 0.4817 1.3744 2.7694 0.7451
P 0.3711 0.7038 0.4239 0.2874 12.8375 0.7555 0.6889 0.2818 0.3635 0.4431
S 0.4289 0.9319 0.5986 0.4400 0.7555 3.8428 1.6139 0.3853 0.5575 0.5652
T 0.6603 0.7929 0.7938 0.4817 0.6889 1.6139 4.8321 0.4309 0.5732 0.9809
W 0.5680 0.3589 0.6103 1.3744 0.2818 0.3853 0.4309 38.1078 2.1098 0.3745
Y 0.6921 0.5322 0.7084 2.7694 0.3635 0.5575 0.5732 2.1098 9.8322 0.6580
V 1.3142 0.4565 1.2689 0.7451 0.4431 0.5652 0.9809 0.3745 0.6580 3.6922
Table 8: The BLOSUM62-2 matrix.
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A Alanine L Leucine
R Arginine K Lysine
N Asparagine M Methionine
D Aspartic acid F Phenylalanine
C Cysteine P Proline
Q Glutamine S Serine
E Glutamic acid T Threonine
G Glycine W Tryptophan
H Histidine Y Tyrosine
I Isoleucine V Valine
Table 9: The list of the amino acids.
From the Introduction, we see that the matrix Q can be recovered from
the BLOSUM62-2 once the marginal probability vector p is available. The
latter vector is obtained by
p = ([BLOSUM62-2])−1v1,
where v1 = (1, · · · , 1) ∈ R
20 is a vector with all its coordinate being 1. The
matrixQ can be obtained precisely from http://www.ncbi.nlm.nih.gov/IEB/ToolBox/
CPP DOC/lxr/source/src/algo/blast/composition adjustment/
matrix frequency data.c#L391.
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